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ABSTRACT
Background: Canine atopic dermatitis (CAD) is a chronic and inflammatory disease present in veterinary dermatological 
practice. The inflammation in CAD is triggered by environmental allergens and skin microorganisms, which are responsible 
for the worsening of cutaneous lesions. This continuous activation of skin inflammatory process can induce the production 
of free radicals that also contribute to cellular damage and ultimately leads to changes in blood parameters in dogs with 
CAD. Although there are reports of inflammatory parameters in CAD, there are a lack of studies correlating skin lesions, 
blood leukocytes and oxidative stress. Based on that, this study aimed to evaluate the integumentary and systemic inflam-
matory response in dogs with atopic dermatitis. 
Materials, Methods & Results: Dogs with confirmed diagnosis of canine atopic dermatitis (n = 10) were divided in two 
groups according to CADESI-IV: AI, with CADESI between 0-10, AII, with CADESI between 10-34, and control group (n 
= 5). Blood-biochemical and histological analysis were performed to access systemic and cutaneous inflammatory response. 
AII group tended to higher neutrophil and eosinophil counts, as well as neutrophil/lymphocyte ratio (NLR) when compared 
to AI. The albumin was lower in AII compared to AI and control (P < 0.05), while total bilirubin and malondialdehyde 
(MDA) did not differ between groups. NLR (r = 0.64 and P = 0.04) and MDA (r = 0.54 and P = 0.1) were positively cor-
related with CADESI, while albumin was negatively correlated with CADESI (r = -0.79 and P = 0.005). Histopathological 
analysis revealed a larger number of neutrophils, macrophages and mast cells in AI and AII than in control group (P < 0.05). 
Discussion: In this study it was possible to evaluate the systemic and cutaneous leukocyte dynamics in CAD. Skin inflam-
mation induces the production of chemotactic molecules contribute to neutrophil outflow from blood vessel toward the 
affected tissue, which can be visualized as perivascular inflammatory infiltrate and exocytosis. At systemic level, there was 
a tendency to increase in total leukocytes and circulating neutrophil count in group AII, as well as in neutrophil/lymphocyte 
ratio (NLR), when compared to AI. The NLR is a widely available and inexpensive laboratory biomarker that quantifies 
systemic inflammation, being used in human medicine to evaluate prognosis in different types of cancer. In our study, dogs 
in AII group showed an increased NLR compared to AI and control, which demonstrates the influence of skin injury in 
systemic parameters. Furthermore, AII group is composed of dogs with greater lesion state, which reflects in higher NLR 
values. Since this disease is known by its chronicity and may remain stable for years, NLR may be a novel biomarker to 
evaluate acute exacerbation in CAD and could potentially explain why some patients have longer crisis duration and frequent 
flares. The maintenance of the inflammatory state also induces the production of oxidizing substances, which possibly exceed 
the total antioxidant capacity, generating a situation of oxidative stress, which can result in damage to membrane lipids and 
release of their products. MDA is reliable and is the most commonly used marker of the overall lipid peroxidation level 
and the presence of oxidative stress. This result may be related with the antioxidant system, such as albumin and bilirubin, 
which was able to promote an efficient control of oxidant substances. In conclusion, the presented data demonstrated an 
inflammatory process progression as well as introduced NLR as a potential marker of disease exacerbation in CAD.
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INTRODUCTION
Canine atopic dermatitis (CAD) is a chronic, 
pruritic and inflammatory skin disease that has a mul-
tifactorial etiology and may be mainly associated with 
genetic predisposition, changes in epidermal barrier and 
microbial imbalance [7,30]. These factors activate the 
immune system, triggering an inflammatory process 
that culminates in tissue damage and ultimately leads to 
systemic changes [34,35]. Pruritus is the main clinical 
manifestation of CAD, but erythema, alopecia, hyperpig-
mentation and lichenification can also be present [10,11].
The inflammatory process in CAD contributes to 
altering and reducing the diversity of the skin microbiota, 
which facilitates the establishment of recurrent skin in-
fections [26]. Bacterial and fungal overgrowth, known as 
dysbiosis, are the most common observed manifestations, 
mainly by Staphylococcus pseudintermedius and Malas-
sezia spp. [6,13] and are associated with exacerbation and 
maintenance of inflammatory process [28].
The activation of inflammatory cells induces 
the production of free radicals, which may oxidate 
cellular membrane and potentially contributes to im-
munopathogenesis of CAD [2,5,15]. To control the 
oxidative skin damage, enzymatic and nonenzymatic 
antioxidant molecules are activated in order to improve 
the defense systems and neutralize free radicals [21].
To assess tissue damage in CAD, a clinical mea-
surement of the integumentary inflammatory process was 
proposed, based on the analysis of lesion patterns [25]. In 
this sense, the aim of the present study was to evaluate the 
tissue and systemic inflammatory response according to 
skin lesion grade of dogs with atopic dermatitis.
MATERIALS AND METHODS
Animal sampling
Fifteen dogs of different breeds from the Met-
ropolitan Region of Fortaleza, ranging in age from 01 
to 08 years-old, were included in the study. The dogs in 
experimental group (n = 10) have history and clinical 
signs compatible with CAD [11] in addition to being 
submitted to exclusion of other pruritic dermatopathies 
through skin scrapping, fungal culture and elimination 
diet. The control group (n = 5) was consisted of dogs 
from Ceara Fire Department, and presented clinical 
and pathological evaluation within normal range for the 
species. All dogs were seronegative for Leishmaniasis 
and had no use of immunosuppressive drugs for two 
weeks prior to biopsy.
The experimental group was further clinically 
evaluated according to the criteria established by the 
International Committee on Allergic Diseases of Ani-
mals (ICADA). These criteria use lesion parameters 
at specific anatomical sites (Canine Atopic Dermatitis 
Severity Index 4 - CADESI IV), allowing the classifi-
cation of the disease in: CAD in remission: up to 10; 
Mild CAD: between 10-34; Moderate CAD: between 
35-59; Severe CAD: between 60-180 [25].
Blood sampling and hemato-biochemical analysis
Blood samples were collected by jugular ve-
nipuncture and stored in EDTA and non-anticoagulant 
tubes for evaluation of systemic parameters. The fol-
lowing parameters were evaluated: total leukocytes, 
neutrophils, lymphocytes, eosinophils, neutrophil/
lymphocyte ratio and biochemical parameters as se-
rum albumin, total bilirubin, alanine aminotransferase 
(ALT), creatinine and malondialdehyde (MDA). 
To evaluate lipid peroxidation, MDA analysis 
was performed, where 250 μL of serum was added to 
400 μL of perchloric acid1 (35%) and taken to water 
bath (37°C, 01h). The mixture was centrifuged (1400 
g; 10 min) and 600 μL of the supernatant was added to 
200 μL of 1.2% thiobarbituric acid2. This mixture was 
taken to water bath (95°C, 30 min). After cooling, the 
reading was performed in a spectrophotometer (535 
nm). The results obtained were expressed as nmol/
mL [9].
Tissue sampling
For histopathological analysis, skin biopsies 
were collected from ventral areas with inflammatory le-
sions using a 5 mm punch. Papules and pustules, if pres-
ent, were avoided. Skin biopsy of control animals was 
also performed from the same regions. The samples were 
fixed in 10% buffered formalin and further processed by 
conventional histological techniques. Histological sec-
tions were stained with Hematoxylin and Eosin1 (H&E) 
for analysis of histological changes and Toluidine Blue1 
for mast cell evaluation. Qualitative evaluation of mor-
phological and morphometric parameters was performed 
and these parameters were classified as present or absent. 
For inflammatory cells evaluation, a quantitative analysis 
was performed in 10 different fields. The analyzes were 
performed under light microscope with magnification 
of 200 x and 400 x, according to the average subjective 
perception of two observers.
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Statistical analysis
Statistical analysis was performed with the aid 
of Graph Pad® software3. Student’s t-test was used to 
evaluate differences in values determined between con-
trol and atopic groups. The correlation between CADESI 
and NLR, Albumin and MDA parameters were evaluated 
with Pearson’s correlation test. In all cases, differences 
were considered significant when P < 0.05. 
RESULTS
Clinical parameters
As previously reported, the clinical evaluation of 
dogs was based on CADESI-IV, which provides lesion 
scores according to the following alterations: erythema, 
lichenification and excoriation/alopecia. Subsequently, 
dogs with atopic dermatitis were divided into two groups: 
Atopy I (AI), dogs with CADESI between 0-10, and 
Atopy II (AII), dogs with CADESI between 10-34. The 
third group was composed of control dogs, which had no 
clinical or hemato-biochemical abnormalities (C).
Systemic inflammatory parameters
The evaluation of systemic inflammation was 
based on parameters of leukogram, albumin and MDA 
(Table 1). There was an increase in neutrophil and eo-
sinophil count as well as in neutrophil/lymphocyte ratio 
(NLR) in group AII when compared to control group. 
There was no difference in total leukocytes, neutrophils, 
NLR, and eosinophils between AI and AII, although an 
increasing tendency was observed in AII. A moderate 
positive and significant correlation between NLR and 
CADESI was observed (r = 0.64 and P = 0.04)
Regarding biochemical evaluations (Table 1), 
the AII group presented lower albumin concentration 
than control and AI groups, while Total Bilirubin and se-
rum MDA levels did not vary between groups. A strong 
negative and significant correlation between Albumin 
and CADESI was observed (r = -0.79 and P = 0.005), 
while moderate positive correlation between MDA and 
CADESI was observed, although this correlation was 
not statistically significant (r = 0.54 and P = 0.1).
Cutaneous inflammatory parameters
Epidermal alterations and dermal inflammatory 
infiltrate were observed in groups AI and AII, whose 
data are provided in Table 2. Atopic animals presented 
acanthosis, hydropic degeneration, spongiosis, exocytosis 
and orthokeratosis in epidermal layer (Figure 1B and 1C). 
Regarding dermal perivascular inflamma-
tory infiltrate, it was characterized by neutrophils, 
eosinophils, lymphocytes, macrophages, and mast 
cells (Figure 1E, 1F, 1H, and 1I). The quantification 
of these cells was also performed, and an increase of 
neutrophils, mast cells and macrophages were observed 
infiltrating the dermis of atopic dogs when compared 
to control group (P < 0.05) [Table 2]. The difference 
between groups AI and AII, however, was not observed.
Figure 1. Histopathological aspects of dogs with CAD. A & D- Represent 
the control group (H&E), which shows no visible dermal and epidermal 
changes. B- It is possible to observe the epidermal layer thickening (H&E). 
C- There is epidermal thickening, hydropic degeneration of keratinocytes, 
as well as neutrophilic exocytosis (H&E). E & F- Highlight the presence of 
inflammatory infiltrate in dermis of atopic dogs (H&E). H & I- It is possible 
to observe mast cells composing the dermal inflammatory cells of atopic 
dogs. G- Represents the control group, with a reduced number of these 
cells (Toluidine Blue). [Scale bar= 1 μm]. Original magnification: 400x.
DISCUSSION
Canine atopic dermatitis is an inflammatory 
skin disease that involves a complex immunopathologi-
cal mechanism [30]. This disease presents clinically in 
different ways, requiring an individual approach accord-
ing to lesion degree. In the present study, the leukocyte 
analysis was performed to assess inflammatory response, 
while albumin, total bilirubin and MDA evaluation 
aimed to estimate oxidative disturbs. Although other 
studies have already been performed correlating CA-
DESI with blood parameters and lymphocytic pheno-
type in CAD [22], no clinical research was previously 
performed correlating blood and tissue inflammatory 
response in this disease according to CADESI. 
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Table 1. Hematological, biochemical and clinical assessment parameters in control and atopic dogs.
Hemato-Biochemical Parameter Control Atopy I (AI) Atopy II (AII)
Total Leukocytes (103/μL) 10.20 ± 1.53 8.52 ± 0.82 11.58 ± 2.01
Neutrophils (103/μL) 6.38 ± 0.96a 6.39 ± 0.89ab 8.21 ± 1.99b
Lymphocytes (103/μL) 1.98 ± 0.81 1.25 ± 0.16 1.57 ± 0.83
Neu/Lym Ratio 3.77 ± 1.3a 5.18 ± 1.1ab 6.27 ± 1.8b
Eosinophils (cells/μL) 102 ± 98.4a 272.2 ± 126.9ab 466.2 ± 216.1b
Albumin (g/dL) 3.49 ± 0.1a 3.54 ± 0.3a 2.78 ± 0.3b
Creatinine (mg/dL) 0.9 ± 0.3 1.1 ± 0.1 1.2 ± 0.1
ALT (U/L) 58.1 ± 20.3 44.7 ± 30.2 60.4 ± 25.1
Total Bilirubin 0.4 ± 0.2 0.6 ± 0.5 0.5 ± 0.4
Total Protein (g/dL) 7.04 ± 0.2 7.94 ± 0.4 7.12 ± 0.9
MDA (nmol/mL) 0.86 ± 0.09 0.87 ± 0.08 0.91 ± 0.15
CADESI-IV 7.6 ± 1.5a 29.6 ± 10.8b
Results are expressed as the mean ± standard deviation. Different letters show statistically significant 
differences (P ≤ 0.05) among control and atopic groups.
Table 2. Histopathological changes in control and atopic dogs. 
Epidermal Alteration Control Atopy I (n = 5) Atopy II (n = 5)
Acanthosis Absent Present (n = 2) Present (n = 3)
Hydropic Degeneration Absent Present (n = 2) Present (n = 2)
Spongiosis Absent Present (n = 2) Present (n = 2)
Exocytosis Absent Absent Present (n = 1)
Parakeratosis Absent Absent Absent
Orthokeratosis Absent Present (n = 2) Present (n = 1)
Inflammatory Cells in Dermis
Neutrophils 0 11.3 ± 8.12ab 25.4 ± 14.7b
Eosinophils 0 7.8 ± 3.4 9.2 ± 5.6
Lymphocytes 0 8.4 ± 3.3 14.7 ± 6.9
Plasma Cells 0 0 0
Macrophages 11.2 ± 7.4a 21.3 ± 11.7ab 33.6 ± 10.1b
Mast Cells 6.1 ± 0.89a 18.4 ± 7.86b 19.8 ± 11.8b
Results are expressed as number of affected dogs/total of dogs for epidermal changes. Neutrophils, eosinophils, lymphocytes, plasma 
cells, macrophages and mast cells are expressed as mean ± standard deviation. Different letters show statistically significant differences 
(P ≤ 0.05) among control and atopic groups.
In this study, it was possible to evaluate the 
systemic and cutaneous leukocyte dynamics in CAD. 
At systemic level, there was a tendency to increase in 
total leukocytes and circulating neutrophil count in 
group AII, as well as in neutrophil/lymphocyte ratio 
(NLR), when compared to AI. At tissue level, it was 
observed a neutrophil accumulation in perivascular 
inflammatory infiltrate, and sometimes the migration 
of these cells towards the epidermis (Figure 1C). 
Skin inflammation induces the production of 
chemotactic molecules such as CXCL1, CXCL2 and 
granulocyte colony stimulating factor (GCS-F), which, 
together with vascular adhesion molecules [24], con-
tribute to neutrophil outflow from blood vessel toward 
the affected tissue [29]. These data represent the main-
tenance of a proinflammatory state in these animals that 
may be related to increased tissue demand. It should 
also be noted that, although the animals in AI group 
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have a stabilized disease, it is possible to visualize a 
potentially more inflammable tissue than the animals 
in control group.
The NLR is a widely available and inexpensive 
laboratory biomarker that quantifies systemic inflam-
mation, being used in human medicine to evaluate 
prognosis in different types of cancer [8,20]. Recently, 
its use in inflammatory diseases, such as asthma and 
atopy, has been highlighted, providing valuable infor-
mation about disease severity [16,32]. In human atopic 
dermatitis it has been shown a positive correlation 
between NLR and lesional score [16], which makes it 
a potential marker to assess disease activity. 
In veterinary medicine, there are few reports 
of NLR analysis in dogs [27]. In our study, dogs in AII 
group showed an increased NLR compared to AI and 
control, which demonstrates the influence of skin injury 
in systemic parameters. Furthermore, AII group is com-
posed of dogs with greater lesional state, which reflects 
in higher NLR values. Since this disease is known by 
its chronicity and may remain stable for years, NLR 
may be a novel biomarker to evaluate acute exacerba-
tion in CAD and could potentially explain why some 
patients have longer crisis duration and frequent flares. 
 In atopic dermatitis, the skin barrier break-
down occurs due to lipoprotein changes in epidermis, 
which favor the penetration of environmental allergens 
and commensal microorganisms [30]. These antigens 
induce a tissue inflammatory response, with the par-
ticipation of innate lymphoid cells-2 (ILC2) and Th2 
cells with consequent production of proinflammatory 
cytokines such as IL-4, IL-5, IL-10 and IL-13, culmi-
nating in IgE synthesis, mast cell degranulation and 
eosinophil migration to the inflammatory site [35]. This 
immunological mechanism favors the mobilization of 
mast cells and eosinophils in groups AI and AII, which 
can be visualized in histological findings (Figure 1F 
and 1I) [Table 1].
Eosinophils are effector cells of innate and 
adaptive immunities, exerting their function by ac-
tivating and releasing substances present in their 
cytoplasmic granules [3]. Eosinophilic migration to 
the inflammatory site is mediated by eotaxins, whose 
synthesis is induced by Th2 cytokines, such as IL-4 
and IL-13 [1,31], and is further influenced by Thymic 
Stromal Lymphopoietin (TSLP), an epithelial cytokine 
involved in immunopathogenesis of atopic dermatitis 
[37]. When combined, such cytokines regulate the 
expression of adhesion molecules, facilitating the ar-
rival of eosinophils at the inflammatory site [36,37]. 
The presence of these cells favors the maintenance 
of inflammation in local microenvironment, cellular 
signaling and consequent tissue destruction [3,4]. The 
persistence of the process affects the skin, resulting 
in thickening, hydropic degeneration and intercel-
lular edema [23], which were observed in this study 
(Figure 1C).
The maintenance of the inflammatory state also 
induces the production of oxidizing substances, which 
possibly exceed the total antioxidant capacity, generat-
ing a situation of oxidative stress [15]. This imbalance 
can be assessed directly or indirectly by measuring 
lipid peroxidation products such as MDA and acute 
phase proteins such as albumin [17]. Serum albumin 
levels differed between groups, being reduced in AII 
group, when compared to AI and control. Albumin is 
a non-enzymatic antioxidant considered to have anti-
inflammatory and immunomodulatory activities [19]. 
Therefore, when there is a systemic inflammatory 
response, there is a reduction in its concentration in 
order to control the damage by oxidizing substances, 
as observed in AII. 
Among non-enzymatic antioxidants, bilirubin 
stands out due to its ability to interact and neutralize 
oxidizing agents, forming hydrophilic substances that 
will be eliminated by urine [33]. In the present study, 
it was not possible to observe a difference in serum 
bilirubin concentration in the evaluated groups. Based 
on this, it is hypothesized that the consumption of 
other antioxidants, such as albumin, has priority when 
compared to bilirubin, and that more intense oxidative 
processes would be necessary to promote changes in 
serum bilirubin values, since the animals in the present 
study had mild lesion grade. 
Inflammatory response in CAD includes oxida-
tive stress, which can result in damage to membrane 
lipids and release of their products [12,18]. MDA is 
reliable and is the most commonly used marker of the 
overall lipid peroxidation level and the presence of 
oxidative stress [14], being positively correlated with 
skin injury in CAD, supporting the hypothesis that 
increased production of oxidizing agents during the 
inflammatory process may contribute to tissue dam-
age [18]. In the present study, although an increasing 
tendency in MDA was showed in AII group, no differ-
ence between groups was observed. This result may be 
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related with the antioxidant system, such as albumin 
and bilirubin, which was able to promote an efficient 
control of oxidant substances.
CONCLUSION
The presented data demonstrate an increase 
in systemic and tissue inflammatory response in dogs 
with atopic dermatitis. The inflammation, however, 
did not interfere in oxidative balance of the organism 
in order to cause systemic illness, being necessary 
studies involving animals with higher lesion grade 
to evaluate the repercussion of tissue inflammation 
in homeostasis breakdown. Among the limitations of 
the study, we highlight the number of dogs, given the 
difficulty of meeting the inclusion criteria. However, 
it is noteworthy that this is the first clinical study to 
evaluate and correlate inflammatory parameters in 
CAD according to CADESI, providing relevant data 
for disease follow-up and monitoring.
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